Publications

Lee JY, Kim JW, Lim MC, Kim S, Kim HS, Choi CH, et al. A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D. J Gynecol Oncol. 2019;30(6):e112.

PMID: 31576697 DOI: 10.3802/jgo.2019.30.e112

Lee JY, Yi JY, Kim HS, Lim J, Kim S, Nam BH, et al. An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION. Jpn J Clin Oncol. 2019;49(8):789-92.

PMID: 31671191 DOI: 10.1093/jjco/hyz085